Boston Scientific Revenue 2010-2025 | BSX
Boston Scientific annual/quarterly revenue history and growth rate from 2010 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Boston Scientific revenue for the quarter ending March 31, 2025 was $4.663B, a 20.93% increase year-over-year.
- Boston Scientific revenue for the twelve months ending March 31, 2025 was $17.554B, a 19.36% increase year-over-year.
- Boston Scientific annual revenue for 2024 was $16.747B, a 17.61% increase from 2023.
- Boston Scientific annual revenue for 2023 was $14.24B, a 12.29% increase from 2022.
- Boston Scientific annual revenue for 2022 was $12.682B, a 6.68% increase from 2021.
| Boston Scientific Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $16,747 |
| 2023 | $14,240 |
| 2022 | $12,682 |
| 2021 | $11,888 |
| 2020 | $9,913 |
| 2019 | $10,735 |
| 2018 | $9,823 |
| 2017 | $9,048 |
| 2016 | $8,386 |
| 2015 | $7,477 |
| 2014 | $7,380 |
| 2013 | $7,143 |
| 2012 | $7,249 |
| 2011 | $7,622 |
| 2010 | $7,806 |
| 2009 | $8,188 |
| Boston Scientific Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-03-31 | $4,663 |
| 2024-12-31 | $4,562 |
| 2024-09-30 | $4,209 |
| 2024-06-30 | $4,120 |
| 2024-03-31 | $3,856 |
| 2023-12-31 | $3,725 |
| 2023-09-30 | $3,527 |
| 2023-06-30 | $3,599 |
| 2023-03-31 | $3,389 |
| 2022-12-31 | $3,242 |
| 2022-09-30 | $3,170 |
| 2022-06-30 | $3,244 |
| 2022-03-31 | $3,026 |
| 2021-12-31 | $3,127 |
| 2021-09-30 | $2,932 |
| 2021-06-30 | $3,077 |
| 2021-03-31 | $2,752 |
| 2020-12-31 | $2,708 |
| 2020-09-30 | $2,659 |
| 2020-06-30 | $2,003 |
| 2020-03-31 | $2,543 |
| 2019-12-31 | $2,904 |
| 2019-09-30 | $2,707 |
| 2019-06-30 | $2,631 |
| 2019-03-31 | $2,493 |
| 2018-12-31 | $2,561 |
| 2018-09-30 | $2,393 |
| 2018-06-30 | $2,490 |
| 2018-03-31 | $2,379 |
| 2017-12-31 | $2,409 |
| 2017-09-30 | $2,222 |
| 2017-06-30 | $2,257 |
| 2017-03-31 | $2,160 |
| 2016-12-31 | $2,191 |
| 2016-09-30 | $2,105 |
| 2016-06-30 | $2,126 |
| 2016-03-31 | $1,964 |
| 2015-12-31 | $1,978 |
| 2015-09-30 | $1,888 |
| 2015-06-30 | $1,843 |
| 2015-03-31 | $1,768 |
| 2014-12-31 | $1,887 |
| 2014-09-30 | $1,846 |
| 2014-06-30 | $1,873 |
| 2014-03-31 | $1,774 |
| 2013-12-31 | $1,838 |
| 2013-09-30 | $1,735 |
| 2013-06-30 | $1,809 |
| 2013-03-31 | $1,761 |
| 2012-12-31 | $1,820 |
| 2012-09-30 | $1,735 |
| 2012-06-30 | $1,828 |
| 2012-03-31 | $1,866 |
| 2011-12-31 | $1,848 |
| 2011-09-30 | $1,874 |
| 2011-06-30 | $1,975 |
| 2011-03-31 | $1,925 |
| 2010-12-31 | $2,002 |
| 2010-09-30 | $1,916 |
| 2010-06-30 | $1,928 |
| 2010-03-31 | $1,960 |
| 2009-12-31 | $2,079 |
| 2009-09-30 | $2,025 |
| 2009-06-30 | $2,074 |
| 2009-03-31 | $2,010 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $157.605B | $16.747B |
| Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and Neuro and MedSurg. While Cardiovascular includes Interventional Cardiology and Peripheral Interventions, Rhythm and Neuro comprises Cardiac Rhythm Management, Electrophysiology and Neuromodulation. The MedSurg group comprises 2 sub segments, viz. Endoscopy, Urology and Pelvic Health. Boston Scientific markets a broad portfolio of internally-developed and self-manufactured drug eluting stents including the Promus PREMIER, Promus Element and Promus Element Plus everolimus-eluting stents. Within the CRM segment, the company deals with implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.799B | 28.11 |
| Stryker (SYK) | United States | $150.214B | 31.41 |
| EssilorLuxottica (ESLOY) | France | $126.765B | 0.00 |
| Medtronic (MDT) | Ireland | $110.324B | 15.64 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.804B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.650B | 26.61 |
| ResMed (RMD) | United States | $37.413B | 28.10 |
| GE HealthCare Technologies (GEHC) | United States | $34.057B | 16.17 |
| Agilent Technologies (A) | United States | $33.852B | 22.07 |
| Terumo (TRUMY) | Japan | $27.835B | 36.15 |
| Koninklijke Philips (PHG) | Netherlands | $23.245B | 16.31 |
| Insulet (PODD) | United States | $22.033B | 86.49 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.095B | 11.62 |
| Baxter (BAX) | United States | $15.595B | 11.64 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.236B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.639B | 23.10 |
| Lantheus Holdings (LNTH) | United States | $5.638B | 14.22 |
| Prestige Consumer Healthcare (PBH) | United States | $3.998B | 17.86 |
| Perrigo (PRGO) | Ireland | $3.649B | 9.25 |
| Haemonetics (HAE) | United States | $3.545B | 16.15 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.334B | 27.70 |
| ICU Medical (ICUI) | United States | $3.244B | 23.92 |
| GN Store Nord (GNNDY) | Denmark | $2.307B | 19.11 |
| QuidelOrtho (QDEL) | United States | $1.952B | 13.43 |
| LeMaitre Vascular (LMAT) | United States | $1.866B | 41.70 |
| AtriCure (ATRC) | United States | $1.598B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.289B | 13.08 |
| Acuren (TIC) | United States | $1.271B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.111B | 25.00 |
| Phibro Animal Health (PAHC) | United States | $1.040B | 13.30 |
| Neogen (NEOG) | United States | $1.027B | 13.14 |
| BioLife Solutions (BLFS) | United States | $1.021B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $0.907B | 0.00 |
| InMode (INMD) | Israel | $0.897B | 9.04 |
| Owens & Minor (OMI) | United States | $0.685B | 5.69 |
| CeriBell (CBLL) | United States | $0.683B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.629B | 0.00 |
| Evolus (EOLS) | United States | $0.589B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.531B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.509B | 0.00 |
| Valneva SE (VALN) | France | $0.494B | 0.00 |
| Surmodics (SRDX) | United States | $0.412B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.403B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.354B | 13.00 |
| Quanterix (QTRX) | United States | $0.332B | 0.00 |
| SNDL (SNDL) | Canada | $0.323B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.274B | 23.07 |
| Cerus (CERS) | United States | $0.271B | 0.00 |
| ZimVie (ZIMV) | United States | $0.258B | 11.72 |
| Sanuwave Health (SNWV) | United States | $0.256B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.253B | 0.00 |
| Brainsway (BWAY) | Israel | $0.250B | 66.10 |
| Cresco Labs (CRLBF) | United States | $0.246B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.233B | 69.17 |
| Biote (BTMD) | United States | $0.230B | 6.46 |
| OraSure Technologies (OSUR) | United States | $0.225B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.224B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.201B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.188B | 15.29 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| High Tide (HITI) | Canada | $0.184B | 0.00 |
| Organigram Global (OGI) | Canada | $0.181B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.177B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.144B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.120B | 0.00 |
| Jin Medical (ZJYL) | China | $0.102B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 11.90 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.082B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| Zynex (ZYXI) | United States | $0.077B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.077B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.077B | 0.00 |
| MacroGenics (MGNX) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.061B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 55.14 |
| United-Guardian (UG) | United States | $0.037B | 12.94 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.027B | 0.00 |
| Safety Shot (SHOT) | United States | $0.023B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |